Alvotech
Biotechnology ResearchReykjavík-1, Iceland1001-5000 Employees
Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars.
Market Expansion Opportunity Alvotech's focus on expanding the availability and accessibility of biosimilars presents a significant opportunity for sales teams to offer complementary supply chain solutions, manufacturing partnerships, or distribution channels that can enhance their market reach and operational efficiency.
Investment & Funding Leverage With recent funding of $78 million and revenue estimates ranging from 50 to 100 million dollars, Alvotech is positioned for growth and innovation, creating potential for sales engagement in technology upgrades, R&D collaborations, and strategic alliances to accelerate their development pipeline.
Technology & Digital Engagement Alvotech utilizes advanced tech stacks like Akamai and Google Tag Manager, indicating openness to digital solutions and data-driven marketing, which suggests opportunities for sales of customer engagement platforms, digital marketing tools, and analytics services.
Industry Trends Alignment Given their leadership in biosimilars and the broader biotech sector trend towards more affordable biologic medicines, sales prospects exist for partnerships with companies focusing on biosimilar formulations, regulatory expertise, or scalable manufacturing technologies.
Competitive Positioning Recent fluctuations in stock interest and share prices highlight a dynamic market sentiment, presenting sales opportunities in investor relations services, corporate branding, or strategic consulting aimed at strengthening Alvotech's market confidence and investor engagement.
Alvotech uses 8 technology products and services including Akamai, Prismic, Backbone.js, and more. Explore Alvotech's tech stack below.
| Alvotech Email Formats | Percentage |
| First.Last@alvotech.com | 95% |
| FirstLa@alvotech.com | 4% |
| FirstL@alvotech.com | 1% |
Biotechnology ResearchReykjavík-1, Iceland1001-5000 Employees
Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars.
Alvotech has raised a total of $78M of funding over 9 rounds. Their latest funding round was raised on Jun 04, 2025 in the amount of $78M.
Alvotech's revenue is estimated to be in the range of $50M$100M
Alvotech has raised a total of $78M of funding over 9 rounds. Their latest funding round was raised on Jun 04, 2025 in the amount of $78M.
Alvotech's revenue is estimated to be in the range of $50M$100M